EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy: A Meta‐Analysis With Reconstructed Time‐to‐Event and Trial Sequential Analysis

Hossam Elbenawi, Youmna Ayman iD, Ahmed Hashim iD, Siddharth Agarwal, Mohamed Wagdy, Belal Mohamed Hamed, Priyesh Thakurathi, Ali Saad Al-Shammari iD, Kareem A Mohamed, Abdul Mukhtadir Kalaiger, Ahmed Ibrahim, Mahmoud Eisa und 12 weitere

Journal of Cardiovascular Electrophysiology · 2025

DOI: 10.1111/jce.70075 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Hossam Elbenawi und 23 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Medicine Department, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Catheter Ablation, Myocardial Ischemia, Cardiomyopathies. Die Arbeit nennt 38 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ventricular tachycardia (VT) is a major contributor to sudden cardiac death among patients with ischemic heart disease (IHD). While catheter ablation reduces the arrhythmic burden, the impact on long‐term outcomes remains uncertain. We assess the efficacy of catheter ablation in patients with IHD.

Methods

We performed a meta‐analysis by systematically searching electronic databases from inception to April 2025. Pairwise, reconstructed time‐to‐event data meta‐analyses and Trial Sequential analyses were conducted.

Results

A total of seven studies (1192 participants) were included. Among patients with IHD with ICD, VT ablation was associated with a significant reduction in ICD shocks (RR = 0.50, 95% CI = [0.34–0.74]), a trend toward reduced VT storm (RR = 0.64, 95% CI = [0.40–1.04], p = 0.07), and lower rates of cardiovascular hospitalization (RR = 0.73, 95% CI = [0.53–1.01], p = 0.06) compared to ICD alone. However, no significant differences were observed when compared to patients receiving ICD plus antiarrhythmic drugs (AADs). VT ablation showed no significant impact on mortality or VT/VF recurrence compared to either ICD alone or ICD with AADs. Reconstructed Kaplan–Meier analysis for all‐cause mortality showed no significant difference between VT ablation and AAD + ICD. Trial Sequential Analysis provided conclusive evidence for VT/VF recurrence, while further data is required for other outcomes.

Conclusion

Among patients with IHD with ICD, VT ablation reduces ICD shocks, VT storm, and cardiovascular hospitalizations compared to ICD‐only therapy, but offers no significant advantage over ICD combined with AADs. VT ablation does not impact overall mortality or the recurrence of VT/VF. Trial sequential analysis confirmed conclusive evidence for VT/VF recurrence, while additional data is needed for other outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tachycardia, VentricularCatheter AblationMyocardial IschemiaCardiomyopathiesElectric CountershockHumansTreatment OutcomeTime FactorsMaleMiddle AgedFemaleRisk FactorsAgedDefibrillators, ImplantableRisk AssessmentHeart RateRecurrenceAction PotentialsDeath, Sudden, Cardiac

Stichwörter der Autor:innen

catheter ablationischemic cardiomyopathymeta‐analysisventricular tachycardia

Autor:innen und Institutionen

  • Cardiovascular Medicine Department, Mayo Clinic, Rochester, Minnesota, USA.
  • Faculty of Medicine, Port Said University, Port Fuad, Egypt.
  • Department of Cardiology, Ain Shams University, Cairo, Egypt.
  • Faculty of Medicine, Modern University for Technology and Information, Cairo, Egypt.
  • Faculty of Medicine, Al-Azhar Cairo University, Cairo, Egypt.
  • Internal Medicine Department, Hartford Hospital, Hartford, Connecticut, USA.

ORCID-Profile: Youmna Ayman, Ahmed Hashim, Ali Saad Al-Shammari, Ramzi Ibrahim, Karol Quelal, Zain Ul Abideen Asad, Konstantinos Siontis, Freddy Del-Carpio Munoz, Christopher V DeSimone, Abhishek J Deshmukh

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Elbenawi, H., Ayman, Y., Hashim, A., Agarwal, S., Wagdy, M., Hamed, B. M., Thakurathi, P., Al-Shammari, A. S., Mohamed, K. A., Kalaiger, A. M., Ibrahim, A., Eisa, M., Ibrahim, R., Zaaya, M., Tan, M. C., Almaadawy, O., Quelal, K., Asad, Z. U. A., Lee, J. Z., …, & Deshmukh, A. J. (2025). Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy: A Meta‐Analysis With Reconstructed Time‐to‐Event and Trial Sequential Analysis. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70075

Vancouver

Elbenawi H, Ayman Y, Hashim A, Agarwal S, Wagdy M, Hamed BM, et al. Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy: A Meta‐Analysis With Reconstructed Time‐to‐Event and Trial Sequential Analysis. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.70075

BibTeX
@article{Elbenawi2025,
  author = {Elbenawi, Hossam and Ayman, Youmna and Hashim, Ahmed and Agarwal, Siddharth and Wagdy, Mohamed and Hamed, Belal Mohamed and Thakurathi, Priyesh and Al-Shammari, Ali Saad and Mohamed, Kareem A and Kalaiger, Abdul Mukhtadir and Ibrahim, Ahmed and Eisa, Mahmoud and Ibrahim, Ramzi and Zaaya, Morad and Tan, Min Choon and Almaadawy, Omar and Quelal, Karol and Asad, Zain Ul Abideen and Lee, Justin Z and Siontis, Konstantinos and Arenal, Ángel and Del-Carpio Munoz, Freddy and DeSimone, Christopher V and Deshmukh, Abhishek J},
  title = {Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy: A Meta‐Analysis With Reconstructed Time‐to‐Event and Trial Sequential Analysis},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2025},
  doi = {10.1111/jce.70075}
}
Kostenlos starten →